Kyle Mikson

Stock Analyst at Canaccord Genuity

(0)
# 4979
Out of 5,319 analysts
88
Total ratings
11.76%
Success rate
-34.58%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
RGEN Repligen
Maintains: Hold
170 150
130.04 15.35% 3 Apr 16, 2025
PACB Pacific Biosciences
Maintains: Buy
3 3
1.16 158.62% 8 Apr 10, 2025
QTRX Quanterix
Maintains: Buy
20 15
5.17 190.14% 5 Mar 18, 2025
ILMN Illumina
Maintains: Hold
135 115
71.2 61.52% 8 Mar 11, 2025
NTRA Natera
Maintains: Strong Buy
180 195
148.1 31.67% 8 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
42 60
45 33.33% 5 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
7.54 138.73% 7 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 7
4.49 55.9% 2 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 4
1.09 221.1% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.21 147.93% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.15 -13.04% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 75
41.5 80.72% 9 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 42
21.52 95.17% 3 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 5
n/a n/a 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
26
n/a n/a 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4
0.54 548.15% 2 Mar 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
n/a n/a 4 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
3
n/a n/a 4 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.49 308.16% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
50
0.71 6829.58% 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
19
3.21 491.9% 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
150
0.08 187400% 1 Jan 29, 2021